In Vivo Tracking of Donor Cells

All animals treated with GFP⁺ Luc⁺ cells, across all groups, were evaluated at 7 day intervals with in vivo fluorescence optical imaging to evaluate persistence, distribution, and relative signal of donor cells using a Xenogen IVIS Imaging System 200 Series (PerkinElmer, MA, USA) [15 (link)].

Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link: Access Free Full Text.

EJAZ A., EPPERLY M.W., HOU W., GREENBERGER J.S, & RUBIN J.P. (2019). Adipose-Derived Stem Cell Therapy Ameliorates Ionizing Irradiation Fibrosis via Hepatocyte Growth Factor-Mediated Transforming Growth Factor-β Downregulation and Recruitment of Bone Marrow Cells. Stem cells (Dayton, Ohio), 37(6), 791-802.

Publication 2019

Xenogen IVIS Imaging System 200 Series

Animals Cells Cells signal Donor Fluorescence

Corresponding Organization : University of Pittsburgh Medical Center

Other organizations : UPMC Hillman Cancer Center

Top 5 similar protocols

Variable analysis

independent variables

Treatment with GFP+ Luc+ cells

dependent variables

Persistence of donor cells
Distribution of donor cells
Relative signal of donor cells

control variables

All animals treated with GFP+ Luc+ cells, across all groups

controls

No positive or negative controls explicitly mentioned

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!